136 related articles for article (PubMed ID: 20153879)
21. Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathway.
Osterlund M; Persson E; Svensson M; Carlsson U; Freskgård PO
Biochem Biophys Res Commun; 2005 Feb; 327(3):789-93. PubMed ID: 15649415
[TBL] [Abstract][Full Text] [Related]
22. Conformational stability of factor VIIa: biophysical studies of thermal and guanidine hydrochloride-induced denaturation.
Freskgârd PO; Petersen LC; Gabriel DA; Li X; Persson E
Biochemistry; 1998 May; 37(20):7203-12. PubMed ID: 9585532
[TBL] [Abstract][Full Text] [Related]
23. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
24. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
Ruf W; Shobe J; Rao SM; Dickinson CD; Olson A; Edgington TS
Biochemistry; 1999 Feb; 38(7):1957-66. PubMed ID: 10026279
[TBL] [Abstract][Full Text] [Related]
25. The quest for Factor VIIa exosite inhibitors.
Amour A; Hutchinson J; Ruiz Avendaño AM; Ratcliffe S; Alvarez E; Martin J; Toomey JR; Senger S; Wolfendale M; Mooney C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):555-8. PubMed ID: 17511650
[TBL] [Abstract][Full Text] [Related]
26. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
Iakhiaev A; Ruf W; Rao LV
Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
[TBL] [Abstract][Full Text] [Related]
27. Peptide exosite inhibitors of factor VIIa as anticoagulants.
Dennis MS; Eigenbrot C; Skelton NJ; Ultsch MH; Santell L; Dwyer MA; O'Connell MP; Lazarus RA
Nature; 2000 Mar; 404(6777):465-70. PubMed ID: 10761907
[TBL] [Abstract][Full Text] [Related]
28. Evidence for activation of tissue factor by an allosteric disulfide bond.
Chen VM; Ahamed J; Versteeg HH; Berndt MC; Ruf W; Hogg PJ
Biochemistry; 2006 Oct; 45(39):12020-8. PubMed ID: 17002301
[TBL] [Abstract][Full Text] [Related]
29. Activation of blood coagulation factor VIIa with cleaved tissue factor extracellular domain and crystallization of the active complex.
Kirchhofer D; Guha A; Nemerson Y; Konigsberg WH; Vilbois F; Chène C; Banner DW; D'Arcy A
Proteins; 1995 Aug; 22(4):419-25. PubMed ID: 7479715
[TBL] [Abstract][Full Text] [Related]
30. A loop of coagulation factor VIIa influencing macromolecular substrate specificity.
Bjelke JR; Persson E; Rasmussen HB; Kragelund BB; Olsen OH
FEBS Lett; 2007 Jan; 581(1):71-6. PubMed ID: 17182039
[TBL] [Abstract][Full Text] [Related]
31. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
[TBL] [Abstract][Full Text] [Related]
32. Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy.
Freskgård PO; Olsen OH; Persson E
Protein Sci; 1996 Aug; 5(8):1531-40. PubMed ID: 8844844
[TBL] [Abstract][Full Text] [Related]
33. Predicted solution structure of zymogen human coagulation FVII.
Perera L; Darden TA; Pedersen LG
J Comput Chem; 2002 Jan; 23(1):35-47. PubMed ID: 11913388
[TBL] [Abstract][Full Text] [Related]
34. Raising the active site of factor VIIa above the membrane surface reduces its procoagulant activity but not factor VII autoactivation.
Waters EK; Yegneswaran S; Morrissey JH
J Biol Chem; 2006 Sep; 281(36):26062-8. PubMed ID: 16835245
[TBL] [Abstract][Full Text] [Related]
35. Probing the S2 site of factor VIIa to generate potent and selective inhibitors: the structure of BCX-3607 in complex with tissue factor-factor VIIa.
Krishnan R; Kotian PL; Chand P; Bantia S; Rowland S; Babu YS
Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):689-97. PubMed ID: 17505107
[TBL] [Abstract][Full Text] [Related]
36. What is wrong with the allosteric disulfide bond hypothesis?
Bach RR; Monroe D
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):1997-8. PubMed ID: 19923558
[No Abstract] [Full Text] [Related]
37. Role of residue Phe225 in the cofactor-mediated, allosteric regulation of the serine protease coagulation factor VIIa.
Petrovan RJ; Ruf W
Biochemistry; 2000 Nov; 39(47):14457-63. PubMed ID: 11087398
[TBL] [Abstract][Full Text] [Related]
38. Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity.
Persson E; Kjalke M; Olsen OH
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13583-8. PubMed ID: 11698657
[TBL] [Abstract][Full Text] [Related]
39. Allosteric activation of coagulation factor VIIa.
Persson E; Olsen OH
Front Biosci (Landmark Ed); 2011 Jun; 16(8):3156-63. PubMed ID: 21622226
[TBL] [Abstract][Full Text] [Related]
40. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa.
Dickinson CD; Kelly CR; Ruf W
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14379-84. PubMed ID: 8962059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
